Found: 14
Select item for more details and to access through your institution.
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report.
- Published in:
- Strahlentherapie und Onkologie, 2024, v. 200, n. 11, p. 983, doi. 10.1007/s00066-024-02256-0
- By:
- Publication type:
- Article
PCR‐Fluo‐ASXL1‐FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignancies.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 5, p. 928, doi. 10.1111/ijlh.13931
- By:
- Publication type:
- Article
Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01372-5
- By:
- Publication type:
- Article
Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. e50, doi. 10.1111/bjh.18961
- By:
- Publication type:
- Article
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 10, p. 1870, doi. 10.1002/ajh.27417
- By:
- Publication type:
- Article
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4028, doi. 10.3390/cancers15164028
- By:
- Publication type:
- Article
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2377, doi. 10.3390/v14112377
- By:
- Publication type:
- Article
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00718-1
- By:
- Publication type:
- Article
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 416, doi. 10.1002/ajh.25004
- By:
- Publication type:
- Article
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13753
- By:
- Publication type:
- Article
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-239
- By:
- Publication type:
- Article
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article